Ali McBride - Publications, H-index & Citations

Ali McBride

University of Arizona

32H指数

395论文数

3.9K被引数

收录论文 42

发表时间

Treatment patterns and outcomes with luspatercept in patients with lower-risk myelodysplastic syndromes: A retrospective US cohort analysis

HEMASPHERE

IF14.6

2024-01-30

OAAI

Mukherjee, Sudipto; Brown-Bickerstaff, Cherrishe; Falkenstein, Angelica; Makinde, Adeola Y.; Bland, Emily; Laney, Jalyna; Garretson, Marne; Huggar, David; Mcbride, Ali

Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review

BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY

IF4.9

2023-11-01

OAAI

Alsuhebany, Nada; Pan, Congshan; Holovac, Eileen; Do, Brian; McBride, Ali

Defining ruxolitinib failure and transition to next-line therapy for patients with myelofibrosis: a modified Delphi panel consensus study

FUTURE ONCOLOGY

IF2.6

2023-05-10

OAAI

Mascarenhas, John; Nguyen, Hiep; Saunders, Ashley; Oliver, Louisa; Tomkinson, Hannah; Perry, Richard; McBride, Ali

Prognostic effect of co-mutations on patients with NPM1+ acute myeloid leukemia (AML) enrolled in the Connect® Myeloid registry

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Maciejewski, Jaroslaw P.; Pollyea, Daniel A.; Roboz, Gail J.; Seiter, Karen; Scott, Bart L.; DeGutis, Irene S.; Kiselev, Pavel; Yu, Edward; McBride, Ali; Heydendael, Willem; Erba, Harry P.

Indirect treatment comparison of oral versus injectable azacitidine as maintenance therapy for acute myeloid leukemia

FUTURE ONCOLOGY

IF2.6

2022-12-12

OAAI

Tabah, Ashley; Huggar, David; Wang, Si-Tien; Johnson, Scott J.; Copher, Ronda M.; O'Connell, Thomas; McBride, Ali; LeBlanc, Thomas W.

Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy 接受强化诱导化疗的美国新诊断急性髓系白血病患者的经济负担

FUTURE ONCOLOGY

IF2.6

2022-10-28

OAAI

Huggar, David; Knoth, Russell L.; Copher, Ronda; Cao, Zhun; Lipkin, Craig; McBride, Ali; LeBlanc, Thomas W.

Cost-Effectiveness and Economic Burden Analyses on All First-Line Treatments of Chronic Lymphocytic Leukemia 慢性淋巴细胞白血病一线治疗的成本效益和经济负担分析

VALUE IN HEALTH

IF6

2022-10-01

PREAI

Alrawashdh, Neda; McBride, Ali; Erstad, Brian; Sweasy, Joann; Persky, Daniel O.; Abraham, Ivo

Health Care Resource Utilization and Total Costs of Care Among Patients with Diffuse Large B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy in the United States

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2022-07-01

OAAI

Keating, Scott J.; Gu, Tao; Jun, Monika P.; McBride, Ali

Retrospective evaluation of safety and effectiveness of same-day pegfilgrastim in patients with lung cancer

FUTURE ONCOLOGY

IF2.6

2022-04-28

OAAI

Alrawashdh, Neda; Vraney, Jamie; Choi, Briana M.; Almutairi, Abdulaali R.; Abraham, Ivo; McBride, Ali

Expanded access to anticancer treatments from conversion to biosimilar pegfilgrastim-cbqv in US breast cancer patients

FUTURE ONCOLOGY

IF2.6

2021-11-08

OAAI

McBride, Ali; Alrawashdh, Neda; MacDonald, Karen; Abraham, Ivo

Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer

FUTURE ONCOLOGY

IF2.6

2021-08-12

OAAI

MacDonald, Karen; Alrawashdh, Neda; McBride, Ali; Abraham, Ivo

Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985-2017)

ANNALS OF HEMATOLOGY

IF2.4

2021-07-19

PREAI

Alrawashdh, Neda; Sweasy, Joann; Erstad, Brian; McBride, Ali; Persky, Daniel O.; Abraham, Ivo

Same-day versus next-day pegfilgrastim or pegfilgrastim-cbqv in patients with lymphoma receiving CHOP-like chemotherapy

FUTURE ONCOLOGY

IF2.6

2021-07-09

OAAI

McBride, Ali; Alrawashdh, Neda; Bartels, Trace; Moore, Logan; Persky, Daniel; Abraham, Ivo

Economic burden of central nervous system metastases in human epidermal growth factor receptor 2-positive breast cancer

FUTURE ONCOLOGY

IF2.6

2021-05-28

OAAI

Schwartz, Naomi R. M.; DeBusk, Kendra; Forero-Torres, Andres; Feliciano, Joseph; Anupindi, Vamshi Ruthwik; Yeaw, Jason; McBride, Ali

Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER-Medicare database

THERAPEUTIC ADVANCES IN DRUG SAFETY

IF3.4

2021-02-02

OAAI

Almutairi, Abdulaati R.; Slack, Marion; Erstad, Brian L.; McBride, Ali; Abraham, Ivo

Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data

EXPERT OPINION ON DRUG SAFETY

IF3.1

2021-01-25

PREAI

Almutairi, Abdulaali R.; Erstad, Brian L.; McBride, Ali; Slack, Marion; Abraham, Ivo

Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis

FRONTIERS IN ONCOLOGY

IF3.3

2020-02-11

128

OAAI

Almutairi, Abdulaali R.; McBride, Ali; Slack, Marion; Erstad, Brian L.; Abraham, Ivo

Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis 质子泵抑制剂暴露与胰腺癌发病风险的meta分析

EXPERT OPINION ON DRUG SAFETY

IF3.1

2020-01-21

PREAI

Alkhushaym, Nasser; Almutairi, Abdulaali R.; Althagafi, Abdulhamid; Fallatah, Saad B.; Oh, Mok; Martin, Jennifer R.; Babiker, Hani M.; McBride, Ali; Abraham, Ivo

Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2019-10-01

PREAI

Almutairi, Abdulaali R.; Alkhatib, Nimer; Martin, Jennifer; Babiker, Hani M.; Garland, Linda L.; McBride, Ali; Abraham, Ivo

RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-Analysis Response

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2019-08-19

OAAI

Oh, Mok; McBride, Ali; Yun, Seongseok; Bhattacharjee, Sandipan; Slack, Marion; Martin, Jennifer R.; Jeter, Joanne; Abraham, Ivo

研究方向